↓ Skip to main content

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients

Overview of attention for article published in Frontiers in immunology, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
11 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
22 Mendeley